Passage Bio, Inc. (PASG)
NASDAQ·Healthcare·Biotechnology
$5.00
+1.01%
Mkt Cap $27.94M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$10.00
Range $7.00 – $15.00
Implied Upside
+100.0%
Consensus $10.00 vs current $5.00
NASDAQ·Healthcare·Biotechnology
$5.00
+1.01%
Mkt Cap $27.94M
No recent rating data.
Price Target (4 analysts)
$10.00
Range $7.00 – $15.00
+100.0%
Consensus $10.00 vs current $5.00